In 1Q16, LabCorp’s (LH) national clinical laboratory business, LabCorp Diagnostics, accounted for 69.3% of the company’s total revenues. Despite facing the impact of about -0.6% in revenues on a ...
Zacks Investment Research on MSN
HOLX vs. LH: Which medtech stock is the stronger investment now?
Hologic HOLX and Labcorp LH are two established MedTech players with a history of collaboration, though each brings distinct strengths. With a market capitalization of $16.71 billion, Hologic ...
Hosted on MSN
LH Q3 Deep Dive: Labcorp Sees Diagnostic Growth, Eyes Specialty Testing and Efficiency Initiatives
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) in Q3 CY2025, with sales up 8.6% year on year to $3.56 billion. Its non-GAAP profit of $4.18 per share was 1% above analysts’ consensus ...
The 2025 guidance anticipates Diagnostics revenue growth of 6.5% to 7.7%, driven equally by organic growth and the annualization of 2024 acquisitions. Biopharma revenue is forecasted to grow 3% to 5%, ...
Labcorp is a global life sciences company headquartered in Burlington, North Carolina. Labcorp provides at-home test kits as well as in-person testing at their laboratory facilities, which are located ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback